Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Currently, there is little to no research on how GLP-1 medication impacts other eating disorders
TB-500 shares a similarly clean safety profile, though theoretical concerns exist regarding its pro-angiogenic and cell-migration properties in the context of existing tumors direct tumorigenic evidence is lacking, but researchers working with tumor models should note the potential interaction
Summary: Retatrutide can cause a dose-dependent increase in resting heart rate, with Phase 2 trials reporting mean rises of approximately 5 to 7 beats per minute at higher doses, likely driven by its GLP-1 and glucagon receptor agonism
PlexusDx serves all 50 states without insurance requirements or membership fees, and your monthly payment is HSA/FSA eligible
US$ 22.01
US$ 21.26
US$ 28.24
US$ 27.50
US$ 29.92
